SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Cardiovascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1753944709104495v1
3/3/187    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Forleo, G. B.
Right arrow Articles by Tondo, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forleo, G. B.
Right arrow Articles by Tondo, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Atrial fibrillation: cure or treat?

Giovanni B. Forleo

Cardiac Arrhythmia and Heart Failure Research Institute, St Camillo-Forlanini Hospital, Catholic University of Sacred Heart. Piazza Carlo Forlanini, 1. 00151, Rome, Italy

Claudio Tondo

Cardiac Arrhythmia and Heart Failure Research Institute, St Camillo-Forlanini Hospital, Catholic University of Sacred Heart. Piazza Carlo Forlanini, 1. 00151, Rome, Italy, c.tondo{at}tiscali.it

Controversies exist with regard to the optimal management of atrial fibrillation (AF). Restoration and maintenance of sinus rhythm is a desirable goal in AF patients because the prevention of recurrences may improve cardiac function, relieve symptoms and should reduce the likelihood of adverse events. Pharmacological therapy for AF has been disappointing with unacceptable rates of AF recurrence and other proarrhythmic sequelae. Recent studies suggested that potential benefit of sinus-rhythm maintenance with respect to mortality may have been neutralized by harmful effects of currently available antiarrhythmic therapies. Because of the inefficacy and dangers with nonablative therapies currently available for maintaining sinus rhythm, alternative treatments are certainly desirable. Curative treatment of atrial fibrillation with catheter ablation is now a legitimate option for a large number of patients. In several studies AF ablation has consistently been demonstrated to be superior to antiarrhythmic medications for the maintenance of sinus rhythm. Nevertheless, many aspects of the therapy are still controversial and large-scale prospective studies are needed to confirm the efficacy and safety of this approach.

Key Words: atrial fibrillation • catheter ablation • antiarrhythmic medications

This version was published on June 1, 2009

Therapeutic Advances in Cardiovascular Disease, Vol. 3, No. 3, 187-196 (2009)
DOI: 10.1177/1753944709104495


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement